SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 187 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $502,000 | -54.6% | 60,008 | -50.9% | 0.01% | -55.6% |
| Q3 2019 | $1,106,000 | -29.8% | 122,180 | +18.0% | 0.03% | -6.9% |
| Q4 2014 | $1,576,000 | +52.0% | 103,585 | +7.7% | 0.03% | +45.0% |
| Q3 2014 | $1,037,000 | +36.8% | 96,180 | +93.8% | 0.02% | +42.9% |
| Q2 2014 | $758,000 | – | 49,628 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |